Completed PHASE2 INTERVENTIONAL 2-arm NCT01079325

Clinical Trial of SB-509 in Subjects With Diabetic Neuropathy

A Phase 2b Repeat Dosing Clinical Trial of SB-509 in Subjects With Moderately Severe Diabetic Neuropathy

Sponsor: Juvenile Diabetes Research Foundation

Conditions Diabetes Mellitus, Type 1 Diabetes Mellitus, Type 2 Diabetic Polyneuropathy

Updated 9 times since 2017 Last updated: May 20, 2022 Started: Nov 30, 2009 Primary completion: May 31, 2015 Completion: Apr 30, 2016

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE2 trial investigates Diabetes Mellitus, Type 1 and Diabetes Mellitus, Type 2 and is currently completed. Juvenile Diabetes Research Foundation leads this study, which shows 9 recorded versions since 2009 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

9 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE2
Jul 2024 — Sep 2024 [monthly]

Completed PHASE2
Jun 2022 — Jul 2024 [monthly]

Completed PHASE2
Apr 2022 — Jun 2022 [monthly]

Completed PHASE2
Jan 2021 — Apr 2022 [monthly]

Completed PHASE2

▶ Show 4 earlier versions

May 2020 — Jan 2021 [monthly]

Completed PHASE2
Jun 2018 — May 2020 [monthly]

Completed PHASE2
Feb 2017 — Jun 2018 [monthly]

Completed PHASE2
Jan 2017 — Feb 2017 [monthly]

Completed PHASE2

First recorded

Nov 2009

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Juvenile Diabetes Research Foundation
Sangamo Therapeutics

Data source: Sangamo Therapeutics

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Boston, United States , Boulder, United States , Chino, United States , Dallas, United States , DeLand, United States , Fort Myers, United States , Fresno, United States , Greer, United States , Houston, United States , Idaho Falls, United States and 21 more locations